Experiencia y porcentaje de complicaciones de las derivaciones portosistémicas intrahepáticas transyugulares en la Fundación Cardioinfantil


Autoria(s): Pierotty Carvajal, Mathieu; Trujillo Calderón, Nasly Stephanie; Cárdenas, Vanessa; Caviedes Gonzalez, Jose Gabriel; Forero Melo, Julian Francisco; Roa Benavides, Jose Luis; Pérez Hidalgo, Juan Manuel
Contribuinte(s)

Caviedes Gonzalez, José Gabriel

Data(s)

17/08/2016

30/08/2017

Resumo

La derivación portosistémica intrahepática transyugular (TIPS) es una técnica importante en el manejo de las complicaciones de la hipertensión portal, en especial en aquellos pacientes candidatos a trasplante hepático. Se trata de un estudio observacional analítico, sin riesgo, en el cual se emplearon técnicas y métodos de investigación documental retrospectivo, y no se realizó ningún tipo de intervención sobre las variables fisiológicas, psicológicas y sociales de la población incluida. Se realizó la descripción demográfica de los pacientes, características clínicas, hallazgos imageneológicos y aspectos técnicos asociados al procedimiento de los pacientes con hipertensión portal que han sido manejados con TIPS en la Fundación CardioInfantil desde Enero 1 de 2007 hasta Junio 30 de 2016. Se incluyeron 54 pacientes de los cuales el 66,7% no presentaron complicaciones inmediatas, tenidas en cuenta desde la terminación del procedimiento y hasta las siguientes 24 horas; sin embargo, 16,9% debutaron con encefalopatía durante este periodo. De las complicaciones tardías, la más frecuente fue la ascitis con un 66,7%, con una mortalidad de 20,4% de los cuales, el 45% de estos fue por shock séptico y falla orgánica secundaria. Aunque el porcentaje de complicaciones asociadas al procedimiento fue alto en nuestros pacientes, se encuentra dentro de los valores reportados en la literatura. Los resultados presentados son un punto de partida para la evaluación del procedimiento en nuestra población y permiten implementar estrategias de mejora que conlleven a incidir de manera positiva en el porcentaje de complicaciones y mortalidad derivadas del procedimiento.

The transjugular intrahepatic portosystemic shunt (TIPS) is an important technique in the management of complications of portal hypertension, especially in patients candidates for liver transplantation. This an analytical observational study, without risk, in which methods and techniques of retrospective documentary research were used, and no type of intervention was conducted on the physiological, psychological and social variables of the population included. We described patient demographic, clinical features, imaging findings and associated fetures with the procedure of patients whith portal hypertension who have been handled with TIPS at Fundación Cardioinfantil, in Bogotá, Colombia, since January 1, 2007 to June 30, 2016. 54 patients where included , of which 66.7% had no immediate complications, taken into account since the end of the procedure and up to 24 hours after; however, they made their debut with encephalopathy 16.9% during this period. As to late complications, the most frequent was ascites with 66.7%, with a mortality of 20.4% of which 45% of these were secondary to septic shock and organ failure. Although the percentage of complications associated with the procedure was high in our patients, is within the values reported in the literature. The results presented are a starting point for the evaluation of the procedure in our population and enable to implement improvement strategies that lead to impact positively on the rate of complications and mortality derived from the procedure.

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/12317

Idioma(s)

spa

Publicador

Facultad de Medicina

Direitos

info:eu-repo/semantics/embargoedAccess

Fonte

instname:Universidad del Rosario

reponame:Repositorio Institucional EdocUR

Cichoz-Lach H, Celinski K, Slomka M, Kasztelan-Szczerbinska B. Pathophysiology of portal hypertension. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2008;59 Suppl 2:231-8.

Sass DA, Chopra KB. Portal Hypertension and Variceal Hemorrhage. Medical Clinics of North America. 2009;93(4):837-53.

Boyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124(6):1700-10.

Toubia N, Sanyal AJ. Portal Hypertension and Variceal Hemorrhage. Medical Clinics of North America. 2008;92(3):551-74.

Jaffe DL, Chung RT, Friedman LS. MANAGEMENT OF PORTAL HYPERTENSION AND ITS COMPLICATIONS. Medical Clinics of North America. 1996;80(5):1021-34.

Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Journal of clinical gastroenterology. 2007;41 Suppl 3:S344-51.

Gronbaek H, Astrup LB, Nielsen DT, Vilstrup H. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis]. Ugeskrift for laeger. 2003;165(5):439-42.

Khanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. Journal of hepatology. 2014;60(2):421-41.

Gupta TK, Chen L, Groszmann RJ. Pathophysiology of portal hypertension. Clinics in liver disease. 1997;1(1):1-12.

Kirby JM, Cho KJ, Midia M. Image-guided intervention in management of complications of portal hypertension: more than TIPS for success. Radiographics : a review publication of the Radiological Society of North America, Inc. 2013;33(5):1473-96.

Smith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982;82(5 Pt 1):968-73.

de Franchis R, Primignani M. Why do varices bleed? Gastroenterology clinics of North America. 1992;21(1):85-101.

Krige JE, Bornman PC, Goldberg PA, Terblanche J. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients. Archives of surgery (Chicago, Ill : 1960). 2000;135(11):1315-22.

Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Seminars in interventional radiology. 2014;31(3):235-42.

Bilbao JI, Quiroga J, Herrero JI, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol. 2002;25(4):251-69.

Ruiz-Blard E, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. [Early Transjugular intrahepatic portosystemic shunt: When, how and in whom?]. Gastroenterol Hepatol. 2015.

Carreiro G, Moreira AL, Murad FF, Azevedo F, Coelho HS. [TIPS - Transjugular intrahepatic portosystemic shunt. A review]. Arquivos de gastroenterologia. 2001;38(1):69-80.

Mauro M, Murphy KPJ, Thomson KR, Venbrux AC, Morgan RA. Trasnyugular Intrahepatic Portosystemic Shunt. In: Elsevier, editor. Imaged-guide Interventions. Second ed: Elsevier; 2014. p. 822-8.

Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology. 1999;30(3):612-22.

Ferguson JW, Hayes PC. Transjugular intrahepatic portosystemic shunt in the prevention of rebleeding in oesophageal varices. European journal of gastroenterology & hepatology. 2006;18(11):1167-71.

García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370-9.

Ditah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis. World journal of hepatology. 2015;7(13):1797-806. 24. Masson S, Mardini HA, Rose JD, Record CO. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM. 2008;101(6):493-501.

Stanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut. 1996;39(3):479-85.

Saravanan R, Nayar M, Gilmore IT, Smart H, McWilliams RG, Rowlands PC, et al. Transjugular intrahepatic portosystemic stent shunt: 11 years' experience at a regional referral centre. European journal of gastroenterology & hepatology. 2005;17(11):1165-71.

Deltenre P, Trepo E, Rudler M, Monescillo A, Fraga M, Denys A, et al. Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials. European journal of gastroenterology & hepatology. 2015;27(9):e1-9.

Mohamed R, Mitchell S. Acurracy of MELD score in predicting mortality in descompensated cirrosis from variceal bleeding, hepatorenal síndrome, alcoholic hepatitis ora cute liver failure as well as mortality after non-transplant surgery or TIPS. Diagnostic disease science. 2011 ; (56) 977-

TEME

Palavras-Chave #Radiología #Radiografía médica #616.07575 #Medicina nuclear #Servicio de Radiología en Hospital #Transyugular intrahepatic postosystemic shunt (TIPS) #Hepatic chirrosis #Portal hypertension #Percutaneous flow reduction of TIPS #Ascitis #Hepatic encephalopathy #Variceal bleeding
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion